Non-linear upside comes from attaching paid governance and reliability to agent rollouts (verification, policy, audit evidence, testing) rather than “more bots.” With net cash, low
capex, and improving execution, UiPath can fund product cycles and buybacks while growing into a higher-quality platform
multiple—if it proves it can run mixed agent+automation workflows safely at scale.